Cook MyoSite: Clinical Trials

15 trials sponsored by Cook MyoSite, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 4 active not recruiting, 1 enrolling by invitation, 1 not yet recruiting. 6 Phase 2, 5 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 26Completed 4, Active not recruiting 1, Terminated 1
Phase 15Active not recruiting 2, Completed 2, Terminated 1
Phase 35Active not recruiting 2, Completed 2, Withdrawn 1

Follow Cook MyoSite: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
REVIVE Prospective Registry Cohort Study
Other: No Intervention (subjects were previously treated with Iltamiocel). This is a observational study and all participants will be observed with no intervention. - Oropharyngeal Dysphagia
Not yet recruitingUniversity of California, Davis312026-08-302026-06-18
Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)
AMDC-USR, Placebo - Stress Urinary Incontinence
Phase 3WithdrawnCook MyoSite2025-06-012024-08-27
Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
iltamiocel - Stress Urinary Incontinence
Enrolling by invitationCook MyoSite962025-04-112026-07-22
Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury
Iltamiocel, Placebo - Fecal Incontinence
Phase 3Active not recruitingCook MyoSite2002024-03-212026-10-20
Autologous Muscle Derived Cells for Treatment of Tongue Dysphagia
Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR), Placebo - Oropharyngeal Dysphagia
Phase 1 / Phase 2Active not recruitingUniversity of California, Davis662022-05-262025-12-12
Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
AMDC-USR (iltamiocel), Placebo - Stress Urinary Incontinence
Phase 3Active not recruitingCook MyoSite962019-04-232026-10-21
Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) for Tongue Dysphagia
Autologous Muscle Derived Cells for Gastro-Intestinal Repair (AMDC-GIR) - Oropharyngeal Dysphagia
Phase 1Active not recruitingPeter Belafsky, MD182017-05-242026-04-20
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
autologous muscle-derived cells (AMDC) - Urinary Incontinence, Stress
Phase 1 / Phase 2CompletedCook MyoSite252015-02-192021-11-01
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Placebo, Iltamiocel - Stress Urinary Incontinence
Phase 3CompletedCook MyoSite3112013-11-212023-01-05
Autologous Cell Therapy for Treatment of Fecal Incontinence
Iltamiocel - Fecal Incontinence
Phase 1 / Phase 2CompletedCook MyoSite532013-03-282024-02-16
Autologous Muscle Derived Cells Female Stress Urinary Incontinence Clinical Study
AMDC-USR, Placebo - Urinary Incontinence, Stress
Phase 3CompletedCook MyoSite1502011-11-042018-05-17
Autologous Cell Therapy for Ischemic Heart Failure
AMDC - Ischemic Heart Disease
Phase 1 / Phase 2TerminatedCook MyoSite92011-02-052021-07-01
Autologous Cell Therapy for Female Stress Urinary Incontinence
Autologous Muscle Derived Cells - Stress Urinary Incontinence
Phase 2CompletedCook MyoSite162010-06-022021-07-01
An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence
autologous muscle cell injection - Stress Urinary Incontinence, Cell Therapy
Phase 2CompletedCook MyoSite662008-10-092023-09-08
Expanded Access Program for Autologous Muscle Derived Cells (AMDCs)
Autologous Muscle Derived Cells (AMDCs)
Temporarily not availableCook MyoSite2026-02-13

Conditions studied

Urinary Incontinence, Stress (8)  ·  Urinary Incontinence (4)  ·  Deglutition Disorders (3)  ·  Lower Urinary Tract Symptoms (3)  ·  Urologic Diseases (3)  ·  Encopresis (2)  ·  Fecal Incontinence (2)  ·  Gastrointestinal Diseases (2)  ·  Intestinal Diseases (2)  ·  Nocturnal Enuresis (2)  ·  Rectal Diseases (2)  ·  Heart Diseases (1)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)

Countries

United States (10)  ·  Canada (5)  ·  United Kingdom (3)  ·  Germany (2)  ·  Belgium (1)

Top investigators

Melissa Kaufman, M.D., Ph.D. (3)  ·  Kenneth Peters, MD (2)  ·  Maggie Kuhn, MD (2)  ·  Peter Belafsky, MD (2)  ·  Ron Jankowski, PhD (2)  ·  Hung Q. Ly, MD (1)  ·  Johnathon D Anderson, PhD (1)  ·  Lesley K. Carr, MD (1)  ·  Lesley K. Carr, MD, FRCSC (1)  ·  Manoj J Raval, MD (1)  ·  Nogah Nativ, PhD (1)  ·  Peter Belafsky, MD, PhD (1)

Results publications

PMID 28734829, PMID 30178605, PMID 37144409, PMID 39282854